journal article Aug 23, 2017

Combination of traditional mutation and metabolic engineering to enhance ansamitocin P‐3 production in Actinosynnema pretiosum

Biotechnology and Bioengineering Vol. 114 No. 12 pp. 2794-2806 · Wiley
View at Publisher Save 10.1002/bit.26396
Abstract
AbstractAnsamitocin P‐3 (AP‐3) is a maytansinoid with its most compelling antitumor activity, however, the low production titer of AP‐3 greatly restricts its wide commercial application. In this work, a combinatorial approach including random mutation and metabolic engineering was conducted to enhance AP‐3 biosynthesis in Actinosynnema pretiosum. First, a mutant strain M was isolated by N‐methyl‐N'‐nitro‐N‐nitrosoguanidine mutation, which could produce AP‐3 almost threefold that of wild type (WT) in 48 deep‐well plates. Then, by overexpressing key biosynthetic genes asmUdpg and asm13‐17 in the M strain, a further 60% increase of AP‐3 production in 250‐ml shake flasks was achieved in the engineered strain M‐asmUdpg:asm13‐17 compared to the M strain, and its maximum AP‐3 production reached 582.7 mg/L, which is the highest as ever reported. Both the gene transcription levels and intracellular intermediate concentrations in AP‐3 biosynthesis pathway were significantly increased in the M and M‐asmUdpg:asm13‐17 during fermentation compared to the WT. The good fermentation performance of the engineered strain was also confirmed in a lab‐scale bioreactor. This work demonstrated that combination of random mutation and metabolic engineering could promote AP‐3 biosynthesis and might be helpful for increasing the production of other industrially important secondary metabolites.
Topics

No keywords indexed for this article. Browse by subject →

References
36
[1]
Bandi S. "Construction of asm2 deletion mutant of Actinosynnema pretiosum and medium optimization for ansamitocin P‐3 production using statistical approach" Journal of Microbiology and Biotechnology (2006)
[2]
Bandi S. "Statistical approach to development of culture medium for ansamitocin P‐3 production with Actinosynnema pretiosum ATCC 31565" Journal of Microbiology and Biotechnology (2005)
[3]
Regulation of secondary metabolism in streptomycetes

Mervyn J Bibb

Current Opinion in Microbiology 10.1016/j.mib.2005.02.016
[4]
Chung J. Byng G. S.2004. MutantActinosynnema pretiosumstrain with increased maytansinoid production. US Patent 6790954.
[11]
Hatano K. "Selective accumulation of ansamitocins P‐2, P‐3 and P‐4, and biosynthetic origins of their acyl moieties" Agricultural and Biological Chemistry (1984)
[17]
Kieser T. (2000)
[25]
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Kenneth J. Livak, Thomas D. Schmittgen

Methods 10.1006/meth.2001.1262
Metrics
25
Citations
36
References
Details
Published
Aug 23, 2017
Vol/Issue
114(12)
Pages
2794-2806
License
View
Authors
Funding
National Natural Science Foundation of China Award: 31370083
Cite This Article
Zhi‐Qiang Du, Yuan Zhang, Zhi‐Gang Qian, et al. (2017). Combination of traditional mutation and metabolic engineering to enhance ansamitocin P‐3 production in Actinosynnema pretiosum. Biotechnology and Bioengineering, 114(12), 2794-2806. https://doi.org/10.1002/bit.26396
Related

You May Also Like

Diffusion characteristics of substrates in Ca‐alginate gel beads

Hideo Tanaka, Masatoshi Matsumura · 1984

583 citations

Fractionating recalcitrant lignocellulose at modest reaction conditions

Yi‐Heng Percival Zhang, Shi‐You Ding · 2007

477 citations

Estimation of diffusion coefficients of proteins

M. E. Young, P. A. Carroad · 1980

475 citations

Dynamic modeling of the central carbon metabolism of Escherichia coli

Christophe Chassagnole, Naruemol Noisommit‐Rizzi · 2002

470 citations